STAT+: PhRMA taps Eric Cantor as new CEO
Eric Cantor, a former GOP House majority leader, is taking the helm of PhRMA at a challenging time for the industry.
Read at STAT News · 29 September 2026 at 17:56
STAT+: PhRMA taps Eric Cantor as new CEO
All coverage of this event, automatically grouped from multiple independent sources.
Last updated: 29 September 2026 at 20:28 · 6 articles · 1 sources
STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company that made a deal with VC firms.
Read at STAT News · 29 September 2026 at 17:54
STAT+: Overton won’t get a vote before midterms
Health department nominees await Senate votes, and we map out what the elections mean for healthy policy.
Read at STAT News · 29 September 2026 at 16:14
STAT+: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event
In this edition of STAT Health Tech: Oura delays IPO plans, Anthropic joins an clinical AI effort by ARPA-H, and MAHA's health data goals.
Read at STAT News · 29 September 2026 at 14:32
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
AstraZeneca is teaming up with Summit Therapeutics to test its PD-1/VEGF bispecific ivonescimab alongside AstraZeneca’s antibody-drug conjugates.
Read at STAT News · 29 September 2026 at 13:52
STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more
Novo has agreed to pay up to $2.6 billion to license an experimental, weekly weight loss pill from China’s Hengrui Pharma
Read at STAT News · 29 September 2026 at 13:25